α2β1 integrin, gpvi receptor, and common fcrγ chain on mouse platelets mediate distinct responses to collagen in models of thrombosis

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Marjoram, Robin J ^a   Li, Zhengzhi ^a   He, Li ^c   Tollefsen, Douglas M ^c   Kunicki, Thomas J ^b   Dickeson, S Kent ^a   Santoro, Samuel A ^a   Zutter, Mary M ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; FCR GAMMA; GLYCOPROTEIN VI RECEPTOR; MEMBRANE RECEPTOR; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2; COLLAGEN; FC RECEPTOR; FIBRINOGEN RECEPTOR; PLATELET MEMBRANE GLYCOPROTEIN VI;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY THROMBOSIS; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE DELETION; HOMEOSTASIS; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; METABOLISM; RAT; THROMBOCYTE; THROMBOSIS;

ANIMALS; BLOOD PLATELETS; COLLAGEN; DISEASE MODELS, ANIMAL; INTEGRIN ALPHA2BETA1; MICE; MICE, KNOCKOUT; PLATELET ACTIVATION; PLATELET MEMBRANE GLYCOPROTEINS; RATS; RECEPTORS, IGG; THROMBOSIS;

EID: 84911948895     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114035     Document Type: Article

References (45)

1. Moroi M, Jung SM, Okuma M, Shinmyozu K. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest. 1989;84:1440-1445.
2. Staatz WD, Rajpara SM, Wayner EA, Carter WG, Santoro SA. The membrane glycoprotein Ia-IIa (VLA-2) complex mediates the Mg++-dependent adhesion of platelets to collagen. J Cell Biol. 1989;108:1917-1924.
3. Kehrel B, Wierwille S, Clemetson KJ, Anders O, Steiner M, et al. Glycoprotein VI is a major collagen receptor for platelet activation: it recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb/IIIa, and von Willebrand factor do not. Blood. 1998;91:491-499.
4. Clemetson JM, Polgar J, Magnenat E, Wells TN, Clemetson KJ. The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors. J Biol Chem. 1999;274:29019-29024.
5. Berlanga O, Tulasne D, Bori T, Snell DC, Miura Y, et al. The Fc receptor gamma-chain is necessary and sufficient to initiate signalling through glycoprotein VI in transfected cells by the snake C-type lectin, convulxin. Eur J Biochem. 2002;269:2951-2960.
6. Moroi M, Jung SM. Platelet glycoprotein VI: its structure and function. Thromb Res. 2004;114:221-233.
7. Kunicki TJ, Orchekowski R, Annis D, Honda Y. Variability of integrin alpha 2 beta 1 activity on human platelets. Blood. 1993;82:2693-2703.
8. He L, Pappan LK, Grenache DG, Li Z, Tollefsen DM, et al. The contributions of the alpha 2 beta 1 integrin to vascular thrombosis in vivo. Blood. 2003;102:3652-3657.
9. Hermans C, Wittevrongel C, Thys C, Smethurst PA, Van Geet C, et al. A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder. J Thromb Haemost. 2009;7:1356-1363.
10. Dumont B, Lasne D, Rothschild C, Bouabdelli M, Ollivier V, et al. Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations. Blood. 2009;114:1900-1903.
11. Boylan B, Chen H, Rathore V, Paddock C, Salacz M, et al. Anti-GPVI-associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRgamma-chain complex from the human platelet surface. Blood. 2004;104:1350-1355.
12. O'Connor MN, Smethurst PA, Davies LW, Joutsi-Korhonen L, Onley DJ, et al. Selective blockade of glycoprotein VI clustering on collagen helices. J Biol Chem. 2006;281:33505-33510.
13. Kasirer-Friede A, Kahn ML, Shattil SJ. Platelet integrins and immunoreceptors. Immunol Rev. 2007;218:247-264.
14. Lockyer S, Okuyama K, Begum S, Le S, Sun B, et al. GPVI-deficient mice lack collagen responses and are protected against experimentally induced pulmonary thromboembolism. Thromb Res. 2006;118:371-380.
15. Kato K, Kanaji T, Russell S, Kunicki TJ, Furihata K, et al. The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion. Blood. 2003;102:1701-1707.
16. Dubois C, Panicot-Dubois L, Merrill-Skoloff G, Furie B, Furie BC. Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo. Blood. 2006;107:3902-3906.
17. Nieswandt B, BergmeierW, Schulte V, Rackebrandt K, Gessner JE, et al. Expression and function of the mouse collagen receptor glycoprotein VI is strictly dependent on its association with the FcRgamma chain. J Biol Chem. 2000;275:23998-24002.
18. Nieswandt B, Schulte V, Bergmeier W, Mokhtari-Nejad R, Rackebrandt K, et al. Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice. J Exp Med. 2001;193:459-469.
19. Nieswandt B, Brakebusch C, Bergmeier W, Schulte V, Bouvard D, et al . Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen. EMBO J. 2001;20:2120-2130.
20. Chen J, Diacovo TG, Grenache DG, Santoro SA, Zutter MM. The alpha(2) integrin subunit-deficient mouse: a multifaceted phenotype including defects of branching morphogenesis and hemostasis. Am J Pathol. 2002;161:337-344.
21. Holtkotter O, Nieswandt B, Smyth N, Muller W, Hafner M, et al. Integrin alpha 2-deficient mice develop normally, are fertile, but display partially defective platelet interaction with collagen. J Biol Chem. 2002;277:10789-10794.
22. Marjoram RJ, Voss B, Pan Y, Dickeson SK, Zutter MM, et al. Suboptimal activation of proteaseactivated receptors enhances alpha2beta1 integrin-mediated platelet adhesion to collagen. J Biol Chem. 2009;284:34640-34647.
23. Saniabadi AR, Umemura K, Matsumoto N, Sakuma S, Nakashima M. Vessel wall injury and arterial thrombosis induced by a photochemical reaction. Thromb Haemost. 1995;73:868-872.
24. Garcia-Mata R, Boulter E, Burridge K. The 'invisible hand': regulation of RHO GTPases by RHOGDIs. Nat Rev Mol Cell Biol. 2011;12:493-504.
25. Cheli Y, Jensen D, Marchese P, Habart D, Wiltshire T, et al. The Modifier of hemostasis (Mh) locus on chromosome 4 controls in vivo hemostasis of Gp6-/- mice. Blood. 2008;111:1266-1273.
26. DerMardirossian C, Rocklin G, Seo JY, Bokoch GM. Phosphorylation of RhoGDI by Src regulates Rho GTPase binding and cytosol-membrane cycling. Mol Biol Cell. 2006;17:4760-4768.
27. Wu Y, Moissoglu K, Wang H, Wang X, Frierson HF, et al. Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function. Proc Natl Acad Sci U S A. 2009;106:5807-5812.
28. Aslan JE, McCarty OJ. Rho GTPases in platelet function. J Thromb Haemost. 2013;11:35-46.
29. Fujioka H, Kikuchi A, Yoshida Y, Kuroda S, Takai Y. A small GTP-binding protein (G protein) recognized by smg p25A GDP dissociation inhibitor (GDI) in human platelet membranes and GDI for this small G protein in human platelet cytosol. Biochem Biophys Res Commun. 1990;168:1244-1252.
30. Hart MJ, Maru Y, Leonard D, Witte ON, Evans T, et al. A GDP dissociation inhibitor that serves as a GTPase inhibitor for the Ras-like protein CDC42Hs. Science. 1992;258:812-815.
31. Leonard D, Hart MJ, Platko JV, Eva A, Henzel W, et al. The identification and characterization of a GDP-dissociation inhibitor (GDI) for the CDC42Hs protein. J Biol Chem. 1992;267:22860-22868.
32. Poole A, Gibbins JM, Turner M, van Vugt MJ, van de Winkel JG, et al. The Fc receptor gamma-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J. 1997;16:2333-2341.
33. Mazzucato M, Cozzi MR, Battiston M, Jandrot-Perrus M, Mongiat M, et al. Distinct spatio-temporal Ca2+ signaling elicited by integrin alpha2beta1 and glycoprotein VI under flow. Blood. 2009;114:2793-2801.
34. Bergmeier W, Stefanini L. Platelet ITAM signaling. Curr Opin Hematol. 2013;20:445-450.
35. Boulaftali Y, Hess PR, Getz TM, Cholka A, Stolla M, et al. Platelet ITAM signaling is critical for vascular integrity in inflammation. J Clin Invest. 2013;123:908-916.
36. Watson SP, Gibbins J. Collagen receptor signalling in platelets: extending the role of the ITAM. Immunol Today. 1998;19:260-264.
37. Takai T, Li M, Sylvestre D, Clynes R, Ravetch JV. FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell. 1994;76:519-529.
38. Clements JL, Lee JR, Gross B, Yang B, Olson JD, et al. Fetal hemorrhage and platelet dysfunction in SLP-76-deficient mice. J Clin Invest. 1999;103:19-25.
39. Nonne C, Lenain N, Hechler B, Mangin P, Cazenave JP, et al. Importance of platelet phospholipase Cgamma2 signaling in arterial thrombosis as a function of lesion severity. Arterioscler Thromb Vasc Biol. 2005;25:1293-1298.
40. Konstantinides S, Ware J, Marchese P, Almus-Jacobs F, Loskutoff DJ, et al. Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis. J Thromb Haemost. 2006;4:2014-2021.
41. Ueno H, Escobedo JA, Williams LT. Dominant-negative mutations of platelet-derived growth factor (PDGF) receptors. Inhibition of receptor function by ligand-dependent formation of heterodimers between PDGF alpha- and beta-receptors. J Biol Chem. 1993;268:22814-22819.
42. Morancho B, Parra-Palau JL, Ibrahim YH, Bernado Morales C, Peg V, et al. A dominant-negative Nterminal fragment of HER2 frequently expressed in breast cancers. Oncogene. 2012.
43. Boylan B, Gao C, Rathore V, Gill JC, Newman DK, et al. Identification of FcgammaRIIa as the ITAMbearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets. Blood. 2008;112:2780-2786.
44. Mangin P, Yap CL, Nonne C, Sturgeon SA, Goncalves I, et al. Thrombin overcomes the thrombosis defect associated with platelet GPVI/FcRgamma deficiency. Blood. 2006;107:4346-4353.
45. Shida Y, Rydz N, Stegner D, Brown C, Mewburn J, et al. Analysis of the role of von Willebrand factor, platelet glycoprotein VI-, and α2β1-mediated collagen binding in thrombus formation. Blood. 2014;124:1799-807.